BG106093A - 14-бета-н-стероли, фармацевтични състави, които ги съдържат и използване на тези производни за получаване на регулиращи мейозата фармацевтични препарати - Google Patents

14-бета-н-стероли, фармацевтични състави, които ги съдържат и използване на тези производни за получаване на регулиращи мейозата фармацевтични препарати

Info

Publication number
BG106093A
BG106093A BG106093A BG10609301A BG106093A BG 106093 A BG106093 A BG 106093A BG 106093 A BG106093 A BG 106093A BG 10609301 A BG10609301 A BG 10609301A BG 106093 A BG106093 A BG 106093A
Authority
BG
Bulgaria
Prior art keywords
14beta
sterols
preparation
pharmaceutical compositions
derivatives
Prior art date
Application number
BG106093A
Other languages
English (en)
Inventor
Peter Esperling
Joachim Kuhnke
Henry Laurent
Thorsten Blume
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG106093A publication Critical patent/BG106093A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Abstract

Изобретението се отнася до фармацевтично активни 14-бета-Н-стероли, приложими за регулиране на мейозата. Те имат обща формула, в която заместителите имат значения, посочени в описанието. Изобретението се отнася и до фармацевтични състави, които ги съдържат, и до използването на тези нови съединенияза получаване на фармацевтични препарати.
BG106093A 1999-05-10 2001-11-09 14-бета-н-стероли, фармацевтични състави, които ги съдържат и използване на тези производни за получаване на регулиращи мейозата фармацевтични препарати BG106093A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99250153 1999-05-10
PCT/EP2000/004092 WO2000068245A1 (en) 1999-05-10 2000-05-05 14β-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS

Publications (1)

Publication Number Publication Date
BG106093A true BG106093A (bg) 2002-05-31

Family

ID=8241145

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106093A BG106093A (bg) 1999-05-10 2001-11-09 14-бета-н-стероли, фармацевтични състави, които ги съдържат и използване на тези производни за получаване на регулиращи мейозата фармацевтични препарати

Country Status (18)

Country Link
EP (1) EP1177205A1 (bg)
JP (1) JP2002544136A (bg)
KR (1) KR20020013541A (bg)
CN (1) CN1350543A (bg)
AU (1) AU4756100A (bg)
BG (1) BG106093A (bg)
BR (1) BR0010449A (bg)
CA (1) CA2373442A1 (bg)
CZ (1) CZ20013981A3 (bg)
EA (1) EA200101157A1 (bg)
EE (1) EE200100592A (bg)
HU (1) HUP0201098A2 (bg)
IL (1) IL145373A0 (bg)
NO (1) NO20015488L (bg)
PL (1) PL352029A1 (bg)
SK (1) SK16212001A3 (bg)
WO (1) WO2000068245A1 (bg)
ZA (1) ZA200110073B (bg)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9376462B2 (en) * 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
CN112334476B (zh) * 2019-09-09 2022-03-15 邦泰生物工程(深圳)有限公司 一种合成鹅去氧胆酸的方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
PL322106A1 (en) * 1995-03-06 1998-01-05 Novo Nordisk As Meiosis stimulation
PL344155A1 (en) * 1998-05-13 2001-10-08 Novo Nordisk As Meiosis regulating compounds

Also Published As

Publication number Publication date
HUP0201098A2 (en) 2002-08-28
ZA200110073B (en) 2003-03-06
NO20015488D0 (no) 2001-11-09
JP2002544136A (ja) 2002-12-24
EE200100592A (et) 2003-02-17
CA2373442A1 (en) 2000-11-16
PL352029A1 (en) 2003-07-28
EP1177205A1 (en) 2002-02-06
SK16212001A3 (sk) 2002-02-05
WO2000068245A1 (en) 2000-11-16
CN1350543A (zh) 2002-05-22
NO20015488L (no) 2002-01-09
KR20020013541A (ko) 2002-02-20
AU4756100A (en) 2000-11-21
BR0010449A (pt) 2002-02-13
CZ20013981A3 (cs) 2002-02-13
IL145373A0 (en) 2002-06-30
EA200101157A1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
CA2290918A1 (en) Heteroaromatic bicyclic derivatives useful as anticancer agents
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
CA2392973A1 (en) Benzoimidazole derivatives useful as antiproliferative agents
MXPA04000577A (es) Derivados de dolastatina 10.
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
BG103417A (bg) Кондензирани бициклични производни на пиримидина
BG106003A (bg) Нови n-цианометиламиди и състави като протеазни инхибитори
MY115662A (en) Novel compounds with analgesic effect
BG103947A (bg) Производни на 9-оксимеритромицин
CA2358998A1 (en) Substituted bicyclic derivatives useful as anticancer agents
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
WO2004020431A3 (en) Novel benzoimidazole derivatives useful as antiproliferative agents
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
GB0102672D0 (en) Compounds
AU3850600A (en) Dalda analogs and their use
AU1247195A (en) Cyclic amide derivatives as neurokinin a antagonists
TW261616B (bg)
GB9502644D0 (en) Heterocyclic derivatives
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
GEP20053617B (en) Bridged Piperazine Derivatives
BG106155A (bg) Нови производни и аналози на галантамин
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
BG103260A (bg) Използване на 1-хидрокси-2-пиридони за лечение насебореен дерматит